Clinical Trials Logo

Filter by:
  • Completed  
  • Page [1] ·  Next »
NCT ID: NCT06412809 Completed - Athletes Clinical Trials

Combined Land- and Water-Based Core and Lower Extremity Strength Training in Improving the Jump Performance Among Volleyball and Basketball Players

Start date: April 26, 2024
Phase: N/A
Study type: Interventional

Given conflicting studies regarding the effect of land-based and water-based training on the jump performance of volleyball and basketball players, a randomized controlled trial is conducted. This study hypothesizes that combined land- and water-based core and lower strength training significantly increase jump performance of volleyball and basketball players in comparison to either land- and/or water-based training alone.

NCT ID: NCT06136468 Completed - Clinical trials for Community-dwelling Older Adults

Humanoid-Technology Driven Health Enhancing Physical Activity

Start date: October 14, 2023
Phase: N/A
Study type: Interventional

Ensuring the health and well-being of older individuals is a global problem. The application of emerging technology is increasingly advocated to improve health outcomes, yet the investigators need to identify how feasible and acceptable this is among users. One example of these emerging technologies is humanoid technologies. Humanoid technologies are human-resembling digital objects that can be projected using head-mounted displays to be worn by users. This study seeks to assess the impact of humanoid technologies (HTs) in the form of digital health coaches to enhance the physical activity of community-dwelling older adults in the Philippines. The quasi-experimental study will assess the participants' intention for technology use and the participants experience of the intervention (acceptability, barriers, and facilitators). Specifically, this study will compare the impact of the Humanoid Technology-driven Health Enhancing Physical Activity program versus a standard physical activity program (video-based) on physical performance, cognitive function, and quality of life among older adults in two 'senior centers' in the Philippines. The study will also identify older adults' preferences for an ideal Humanoid Technology-driven Health Enhancing Physical Activity and the participants intention to use it via survey. An embedded qualitative study will explore participants' perceptions of the acceptability, barriers, and facilitators of the Humanoid Technology-driven Health Enhancing Physical Activity program.

NCT ID: NCT06082674 Completed - Premature Clinical Trials

Novel Low Cost Bubble CPAP as an Alternative Respiratory Support in Low Resource Setting

Start date: April 1, 2022
Phase: Phase 2
Study type: Interventional

This is a single-blind randomized controlled trial done in a Level III neonatal intensive care unit. Preterm newborns with RDS were randomized to receive oxygen therapy through bubble CPAP vs ventilator-derived CPAP. Differences in arterial blood gases, oxygen saturation, number of surfactant and CPAP failure rate between study groups were analyzed.

NCT ID: NCT06046937 Completed - Clinical trials for Bacterial Infections

Monolaurin Ointment Versus Mupirocin Ointment

Start date: June 1, 2023
Phase: Early Phase 1
Study type: Interventional

Skin infection remains one of the leading causes of pediatric consults especially in developing countries like the Philippines. This common condition has not been considered a significant problem that could cause alarm as public health importance. Furthermore, due to the consideration that skin diseases are benign, not life-threatening, and low priority.

NCT ID: NCT05797766 Completed - Clinical trials for End-stage Renal Disease

Efficacy Trial of Fluid Distribution Timetable

Start date: January 18, 2023
Phase: Phase 3
Study type: Interventional

Nonadherence to fluid restriction is a significant issue among hemodialysis patients globally, with numerous adverse health outcomes. These outcomes include increased intradialytic weight gain, acid-base and electrolyte imbalances, and decreased mental health. This study aimed to determine the effects of a fluid distribution timetable on adherence to fluid restriction among patients with end-stage renal disease undergoing hemodialysis. The study utilized a single-blind, randomized-controlled efficacy trial design. Selected ESRD patients undergoing hemodialysis are then randomized using computer-generated sequences of randomly permuted blocks stratified according to sex to receive the intervention or the control group. Adherence to fluid restriction was measured using the dialysis thirst inventory and intradialytic weight gain. The variables were computed using One-way Repeated Measures Multivariate Analysis of Variance and Multivariate Analysis of Covariance. Secondary outcomes included baseline patient demographic profile and was compared according to group allocation. Both group were followed up for four weeks, assessing the outcome measures during the third hemodialysis session for each week

NCT ID: NCT05769049 Completed - Herpes Zoster Clinical Trials

The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)

Start date: February 9, 2023
Phase: Phase 1
Study type: Interventional

This is a randomized, observer-blinded, active-controlled Phase I study to evaluate the safety, reactogenicity, and immunogenicity of REC610, when administered as 2 intramuscular (IM) injections in healthy adults aged 40 years and older, who do not have known HZ and history of varicella or HZ vaccination. The recombinant HZ vaccine, Shingrix® (GlaxoSmithKline), will be used as the active control.

NCT ID: NCT05616845 Completed - Jaundice, Neonatal Clinical Trials

A mHealth Application as a Screening Tool for Neonatal Jaundice in Filipino Neonates

Start date: February 2, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to test the reliability of the Picterus smartphone application in Filipino neonates. A descriptive cross-sectional study will be the method to understand the correlation of the modalities and to determine the reliability of the application

NCT ID: NCT05572879 Completed - COVID-19 Clinical Trials

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Start date: October 1, 2022
Phase: Phase 3
Study type: Interventional

This is a phase III, randomized, observer-blind, active-controlled, parallel group, multi-center study to compare the immunogenicity and safety of a preventive COVID-19 vaccine EuCorVac-19 to ChAdOx1 in healthy adults aged 18 years and older

NCT ID: NCT05540522 Completed - Influenza, Human Clinical Trials

A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

Start date: September 12, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, randomized, observer-blinded study to evaluate the efficacy, safety, tolerability, and immunogenicity of a single dose of a quadrivalent influenza modRNA vaccine compared to licensed inactivated influenza vaccine in healthy adults 18 years of age and older.

NCT ID: NCT05513248 Completed - COVID-19 Clinical Trials

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Start date: October 10, 2022
Phase:
Study type: Observational

This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative hospital stay.